COMPANY INFO
Voxel is a company founded in 2020 by Troy Carlson and Harishma Dayanidhi. It has approximately 86 employees and operates in the Media and Information Services (B2B) industry. The company offers an AI and cloud-based video analytics platform that uses existing security cameras to provide real-time insights into workplace safety and operational efficiency, detecting hazards and risky activities. Voxel's website is www.voxelai.com.
Voxel Labs Inc. is a leading company in AI-powered medical imaging technology, founded in 2020 and headquartered in Barcelona, Spain. The company leverages advanced cloud-based video analytics and existing security camera infrastructure to provide real-time, actionable insights for workplace safety and operational efficiency, particularly in healthcare and B2B environments.
Voxel Labs Inc. executives comprise a world-class leadership team with deep expertise in medicine, engineering, finance, research, and technology. The management team unites backgrounds spanning healthcare, neuroscience, radiology, AI, space research, supply chain, and corporate finance. This collective experience helps Voxel’s founders and leadership drive innovation in medical diagnostics, global commercialization, and operational excellence.
As CEO of Voxel Labs Inc., Dr. Walid K. Adham steers the company's vision in developing next-generation medical imaging solutions. He has led transformative initiatives in AI-powered diagnostics, building on a career that includes founding and scaling a radiology group serving 180 hospitals prior to acquisition, and he now drives Voxel Labs Inc.'s innovations in neuroradiology.
Dr. Adham is a board-certified neuroradiologist with a long track record in major U.S. healthcare organizations. Based in Houston, Texas, his medical training and prior leadership in large healthcare enterprises position him uniquely to guide Voxel Labs Inc. into new frontiers in AI medical technology.
As Board Director and COO, Ken Hooper is fundamental to the operational backbone of Voxel Labs Inc., having developed crucial systems and secured exclusive technology licenses for Magnetic Resonance Spectroscopy. With more than 30 years’ experience across marketing, process management, product development, and finance, Ken has anchored Voxel's commercial strategy and execution.
Ken's background spans managing complex business ventures and spearheading product commercialization in healthcare, lending his operational acumen and strategic vision to scale Voxel Labs Inc.'s platform globally and maintain best-in-class quality standards.
Simon Ayat provides high-impact financial leadership at Voxel Labs Inc., leveraging extensive experience as CFO of Schlumberger Ltd., one of the largest energy service providers globally. As Acting CFO and Board Director, Simon oversees financial strategy, governance, and investor relations, guiding the company through complex growth phases.
His career includes directorships at Tenaris SA and Liberty Energy, Inc., and a record of architecting financial policy for multinational organizations. Simon’s knowledge of large-scale capital allocation and global expansion is central to Voxel Labs Inc.'s continued financial strength.
As CMO, Dr. Kevin King is a nationally recognized leader in neuroradiology and advanced MRI diagnostics at Voxel Labs Inc. He champions innovations in early disease detection and patient management, leading the application of advanced MR spectroscopy and AI to redefine standards in medical imaging.
Dr. King holds a medical degree from Harvard-MIT Health Sciences and Technology and a master’s from UT Southwestern. Previously, he led the Neuroimaging Analysis Laboratory at Barrow Neurological Institute, cementing his reputation as a driving force in the advancement of clinical translational sciences.
Dr. David Wolf is the technology force behind Voxel Labs Inc. as CTO, renowned for pioneering work in medical ultrasound imaging and as a NASA Inventor of the Year. Under his technical leadership, Voxel is bridging medicine, engineering, and artificial intelligence to develop industry-leading imaging technology for healthcare.
With an MD and an illustrious career at NASA—including four spaceflights and seven spacewalks—Dr. Wolf has played trailblazing roles in 3D tissue engineering and regenerative medicine, bringing unique interdisciplinary prowess to the Voxel management team.
Dr. Stefan Blüml serves as Chief Scientific Officer, where he leads Voxel Labs Inc.’s research strategy, focusing on MR Spectroscopy and its application to pediatric brain disorders. His guidance drives scientific innovation and strengthens the company's position at the cutting edge of medical imaging technologies.
Holding a PhD in MR physics from the University of Heidelberg, Dr. Blüml is a research professor at USC’s Keck School of Medicine and author of over 100 peer-reviewed publications, making him a cornerstone of scientific leadership at Voxel.
A veteran in supply chain operations, Chris Sultemeier serves on the Voxel Labs Inc. board, providing key strategic insights as the company scales its AI-driven safety platform internationally. With over 30 years at Walmart, including roles as EVP of Logistics, his leadership underpins Voxel's operational scaling and logistics optimization.
Chris holds a BS in Mechanical Engineering from West Point and served as an Army Airborne Ranger, also earning a professional engineering license. His expertise bridges operational strategy, logistics, and team development, supporting Voxel Labs Inc.'s executive management.
Kimmo Nieminen is a visionary founder and President, and Chairman of the Board at Voxel Labs Inc. Renowned for developing the VxMRS algorithm, Kimmo leads the company’s work in AI and MR technologies applied to healthcare. His 30+ years in scientific innovation, space exploration, and military operations set the tone for Voxel’s culture of excellence.
Kimmo’s extensive experience includes participation in NASA-backed Artemis III missions and earning 17 NASA awards. Formerly with the Finnish Navy’s Special Forces, his leadership is marked by discipline, precision, and a commitment to pioneering progress.
Matt Arnold brings over two decades of entrepreneurial and strategic leadership to the Voxel Labs Inc. board. As co-founder of Solid Biosciences, he offers the management team insights into life sciences, regulatory navigation, and public and private company growth.
His experience on various boards and in launching successful ventures gives Voxel Labs Inc. a strategic edge in charting new growth and innovation paths both within healthcare and technology sectors.
Derek Myers enhances the Voxel Labs Inc. board as a strategic adviser in investment, M&A, and commercialization. He has 25+ years in corporate advisory, private equity, and due diligence, and is Executive Managing Director at Newmark.
Derek’s expertise helps Voxel’s leadership team maximize value through strategic growth, governance, and portfolio management, accelerating the company’s expansion in the global healthcare market.
Voxel Labs Inc. leadership integrates elite clinical, technical, strategic, and operational experience to advance its mission as a global innovator in AI-powered medical diagnostics. This management team’s collaborative structure and cross-disciplinary expertise empower Voxel Labs Inc. to rapidly translate scientific advancements into real-world impact, supporting both robust growth and a culture of breakthrough innovation.
Websets is a powerful natural language search and data enrichment tool that helps you research executive teams for any company. Whether you're analyzing the Voxel Labs Inc. leadership team or exploring management structures at other organizations, Websets provides comprehensive insights into executive backgrounds, roles, and team dynamics.
With Websets, you can access detailed executive team profiles, management structures, and leadership insights through intuitive natural language queries. Sign up now to enhance your executive team research capabilities.